Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hepatitis B, Chronic × Observation × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 19 Prostatic Neoplasms 18 Carcinoma, Non-Small-Cell Lung 17 Neoplasms 16 Colorectal Neoplasms 14 Endometrial Neoplasms 13 Stomach Neoplasms 12 Lung Neoplasms 11 Pancreatic Neoplasms 9 Leukemia, Myeloid, Acute 7 Colonic Neoplasms 7 Carcinoma, Hepatocellular 7 Oropharyngeal Neoplasms 6 Neoplasm Metastasis 6 Multiple Myeloma 6 Lymphoma, Large B-Cell, Diffuse 6 Esophageal Neoplasms 6 Sarcoma 5 Rectal Neoplasms 5 Mouth Neoplasms 5 Melanoma 5 Uterine Cervical Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Recurrence 4 Head and Neck Neoplasms 4 Colorectal Neoplasms, Hereditary Nonpolyposis 4 Brain Neoplasms 4 Anus Neoplasms 4 Urinary Bladder Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3

Interventions

Tenofovir 5 entecavir 2 peginterferon alfa-2b 1 peginterferon alfa-2a 1 ibrutinib 1 Radiofrequency Ablation 1 Observation 1 Nucleosides 1 Methods 1 Interferons 1 Cholecalciferol 1 Acids 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05661786 2022-12-22

PILOT

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis B, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡